drugset

drugset / Trial / NCT03064282

Prostatic Hyperplasia Treatment and Cancer Prevention

NCT03064282 ↗

Phase 0 Unknown 40 enrolled Manchanda Medical Clinic

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Treatment of patients with prostatic hyperplasia with topical papaverine.

Timeline

Start: 2021-06-30
Primary completion: 2021-09-30
Completion: 2021-12-01

Publications

Background Hafez B, Hafez ES. Andropause: endocrinology, erectile dysfunction, and prostate pathophysiology. Arch Androl. 2004 Mar-Apr;50(2):45-68.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Papaverine	Small molecule	—	—

Indications